From Lab to Clinic: Effect of Academia-Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry

A Five-Year Analysis of Market Share and Sales Growth for Original Drugs after Patent Expiration in Korea

Does Firm`s Alliances Increase New Drug Development Time? A Multiple Regression Analysis of Clinical Development Time

Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea: A multilevel analysis

Notable Differences in Drug Lag Between Korea and Japan of New Drugs Between 2009 and 2017

국내 제약기업의 지주회사 전환 전후 연구개발 투자현황 비교

연구자주도임상시험(IIT)의 기업 지원 여부에 따른 유형별 특성 분석 : 연구중심병원 10개 기관 중심으로

국산신약과 최초 혁신신약의 진입시기 격차와 국산신약의 기술혁신 원천 분석 연구

정부R&D 과제 선정 평가 요인 분석 : 범부처신약개발사업단 사례 중심으로 = Key selection factors of Drug Development Project: A Case Study of Korea Drug Development Fund

국내 제약기업의 치료제 질환분야 다각화 결정요인 = The factor influencing therapeutcis diversification in domestic pharmaceutical companies